ORASURE TECHNOLOGIES, INC Acquisitions, Net of Cash Acquired
ORASURE TECHNOLOGIES, INC (OSUR) reported Acquisitions, Net of Cash Acquired of $3.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-03-09
- ORASURE TECHNOLOGIES, INC payments to acquire businesses, net of cash acquired for the quarter ending 2021-06-30 was -$1.00K.
- ORASURE TECHNOLOGIES, INC payments to acquire businesses, net of cash acquired for the quarter ending 2021-03-31 was $19.00K.
- ORASURE TECHNOLOGIES, INC payments to acquire businesses, net of cash acquired for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- ORASURE TECHNOLOGIES, INC payments to acquire businesses, net of cash acquired for the quarter ending 2019-12-31 was $10.58M.
- ORASURE TECHNOLOGIES, INC payments to acquire businesses, net of cash acquired for fiscal 2025 was $3.61M, a 28.27% decline from fiscal 2024.
- ORASURE TECHNOLOGIES, INC payments to acquire businesses, net of cash acquired for fiscal 2024 was $5.04M.
- ORASURE TECHNOLOGIES, INC payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00.
- ORASURE TECHNOLOGIES, INC payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3.61M 10-K · filed 2026-03-09 | |||||
| 2024-12-31 | $5.04M 10-K · filed 2026-03-09 | |||||
| 2023-12-31 | $0.00 10-K · filed 2026-03-09 | |||||
| 2022-12-31 | $0.00 10-K · filed 2025-03-07 | |||||
| 2021-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $18.00K 10-Q · filed 2021-08-05 | $18.00K derived: sum of 3 quarters · filed 2023-03-03 | |||
| 2021-03-31 | $19.00K 10-Q · filed 2021-05-06 | $19.00K derived: sum of 2 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $3.04M 10-K · filed 2023-03-03 | ||||
| 2020-09-30 | $3.04M 10-Q · filed 2021-11-04 | |||||
| 2019-12-31 | $10.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $10.58M derived: sum of 2 quarters · filed 2022-03-01 | $10.54M derived: sum of 3 quarters · filed 2022-03-01 | $23.80M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$39.00K derived: sum of 2 quarters · filed 2020-11-05 | $13.22M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $13.22M 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | $13.26M 10-Q · filed 2020-05-11 | |||||
| 2019-01-04 | $103.00K 10-Q · filed 2019-11-08 | |||||
| 2011-12-31 | -$243.20K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $49.73M 10-K · filed 2014-03-14 | $49.73M 10-K · filed 2012-03-14 | |||
| 2011-09-30 | $49.97M 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |